Skip to content

Drug interactions

Etoposide + Letermovir

Severity: Moderate

Etoposide and Letermovir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir is a moderate CYP3A4 inhibitor and may increase etoposide exposure. This may worsen myelosuppression, notably in transplant patients.

What this interaction means in plain words

Etoposide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Etoposide belongs to Oncology; Letermovir belongs to Anti Virals.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 reduces etoposide clearance.

What to do

Monitor blood counts and etoposide toxicity, and reduce the etoposide dose if adverse effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etoposide and Letermovir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etoposide with Letermovir?

MediHelp rates the interaction as moderate. Etoposide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letermovir is a moderate CYP3A4 inhibitor and may increase etoposide exposure. This may worsen myelosuppression, notably in transplant patients.

How serious is the interaction between Etoposide and Letermovir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and etoposide toxicity, and reduce the etoposide dose if adverse effects occur.

What other medicines interact with Etoposide?

MediHelp also lists interactions of Etoposide with, for example, Adenovirus types 4 and 7 live, Pentostatin, Cyclosporin. The full list is on the Etoposide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in